Synthesis and characterization of a novel inhibitor of C-reactive protein-mediated proinflammatory effects.

BACKGROUND Numerous studies have shown that high C-reactive protein (CRP) levels predict cardiovascular disease and augur a poor prognosis in patients with acute coronary syndromes. Much in vitro and in vivo data support of a role for CRP in atherogenesis. There is an urgent need to develop inhibitors that specifically block the biological effects of CRP in vivo. The one-bead-one-compound (OBOC) combinatorial library method has been used to discover ligands against several biological targets. In this study, we use a novel fluorescence-based screening method to screen an OBOC combinatorial library for the discovery of peptides against human CRP. METHODS Human CRP was labeled with fluorescein isothiocyanate (FITC) and human serum albumin (HuSA) was labeled with phycoerythrin (PE) and used for screening. The OBOC library LWH-01 was synthesized on TentaGel resin beads using a standard solid-phase "split/mix" approach. RESULTS By subtraction screening, eight peptides that bind specifically to CRP and not to HuSA were identified. In human aortic endothelial cells (HAECs) incubated with CRP, inhibitors CRPi-2, CRPi-3, and CRPi-6 significantly inhibited CRP-induced superoxide, cytokine release, and nuclear factor-κB (NFκB) activity. Molecular docking studies demonstrate that CRPi-2 interacts with the two Ca(2+) ions in the single subunit of CRP. The binding of CRPi-2 is reminiscent of choline binding. CONCLUSIONS Future studies will examine the utility of this inhibitor in animal models and clinical trials.

[1]  P. Kollman,et al.  A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules , 1995 .

[2]  L. Zlock,et al.  Definition of a C-reactive protein binding determinant on histones. , 1991, The Journal of biological chemistry.

[3]  M. Pepys,et al.  C-reactive protein and cardiovascular disease: new insights from an old molecule. , 2003, QJM : monthly journal of the Association of Physicians.

[4]  Yan Wang,et al.  Rapid discovery of death ligands with one-bead-two-compound combinatorial library methods. , 2011, ACS combinatorial science.

[5]  P. Kollman,et al.  A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules J. Am. Chem. Soc. 1995, 117, 5179−5197 , 1996 .

[6]  P. Yancey,et al.  Human C-reactive protein promotes oxidized low density lipoprotein uptake and matrix metalloproteinase-9 release in Wistar rats** This work was supported by National Institutes of Health Grant RO1 HL-074360 to I. J. Published, JLR Papers in Press, February 2, 2008. , 2008, Journal of Lipid Research.

[7]  S. Wood,et al.  The physiological structure of human C-reactive protein and its complex with phosphocholine. , 1999, Structure.

[8]  S. Verma,et al.  Is C-reactive protein an innocent bystander or proatherogenic culprit? C-reactive protein promotes atherothrombosis. , 2006, Circulation.

[9]  P. Kollman,et al.  Automatic atom type and bond type perception in molecular mechanical calculations. , 2006, Journal of molecular graphics & modelling.

[10]  M. Freissmuth,et al.  Ligand-based peptide design and combinatorial peptide libraries to target G protein-coupled receptors. , 2010, Current pharmaceutical design.

[11]  Lloyd M. Smith,et al.  Exploration of structure--activity relationships among foldamer ligands for a specific protein binding site via parallel and split-and-mix library synthesis. , 2008, Journal of combinatorial chemistry.

[12]  U. Singh,et al.  C-reactive protein stimulates superoxide anion release and tissue factor activity in vivo. , 2009, Atherosclerosis.

[13]  M. Stuart,et al.  Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein (CRP) , 2009 .

[14]  Saralees Nadarajah,et al.  Letter to the editor , 2007, Int. Trans. Oper. Res..

[15]  P. Libby,et al.  Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. , 2008, The New England journal of medicine.

[16]  Steven V. Ley,et al.  Targeting C-reactive protein for the treatment of cardiovascular disease , 2006, Nature.

[17]  Kit S Lam,et al.  From combinatorial chemistry to cancer-targeting peptides. , 2007, Molecular pharmaceutics.

[18]  S. Balasubramanian,et al.  Discovery of G-quadruplex stabilizing ligands through direct ELISA of a one-bead-one-compound library. , 2006, Organic & biomolecular chemistry.

[19]  Felice C Lightstone,et al.  The Use of One-Bead One-Compound Combinatorial Library Technology to Discover High-Affinity αvβ3 Integrin and Cancer Targeting Arginine-Glycine-Aspartic Acid Ligands with a Built-in Handle , 2010, Molecular Cancer Therapeutics.

[20]  K. Lam,et al.  Automatic Edman microsequencing of peptides containing multiple unnatural amino acids. , 2001, Analytical biochemistry.

[21]  Yoon-Sik Lee,et al.  Antibody-free peptide substrate screening of serine/threonine kinase (protein kinase A) with a biotinylated detection probe. , 2011, Analytical biochemistry.

[22]  Kit S. Lam,et al.  The "One-Bead-One-Compound" Combinatorial Library Method. , 1997, Chemical reviews.

[23]  P. Ridker,et al.  High-sensitivity C-reactive protein: clinical importance. , 2004, Current problems in cardiology.

[24]  J. Kastelein,et al.  In vivo effects of C-reactive protein (CRP)-infusion into humans. , 2005, Circulation research.

[25]  R. Neubig,et al.  Novel Peptide Ligands of RGS4 from a Focused One‐Bead, One‐Compound Library , 2008, Chemical biology & drug design.

[26]  Synthetic Combinatorial Libraries: A New Tool for Drug Design , 1994 .

[27]  J. Kastelein,et al.  Effects of CRP infusion on endothelial function and coagulation in normocholesterolemic and hypercholesterolemic subjects Published, JLR Papers in Press, January 26, 2007. , 2007, Journal of Lipid Research.

[28]  M. Meldal,et al.  Direct visualization of enzyme inhibitors using a portion mixing inhibitor library containing a quenched fluorogenic peptide substrate. Part 1. Inhibitors for subtilisin Carlsberg , 1995 .

[29]  Kit S. Lam,et al.  A new type of synthetic peptide library for identifying ligand-binding activity , 1992, Nature.

[30]  J. Reusch,et al.  C-Reactive Protein Decreases Interleukin-10 Secretion in Activated Human Monocyte-Derived Macrophages via Inhibition of Cyclic AMP Production , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[31]  M. Sanner,et al.  Model of the αLβ2 integrin I‐domain/ICAM‐1 DI interface suggests that subtle changes in loop orientation determine ligand specificity , 2002 .

[32]  K. Lam,et al.  Applications of one-bead one-compound combinatorial libraries and chemical microarrays in signal transduction research. , 2003, Accounts of chemical research.

[33]  M. Pfeffer,et al.  C-reactive protein levels and outcomes after statin therapy. , 2005, The New England journal of medicine.

[34]  Ruiwu Liu,et al.  Combinatorial chemistry identifies high-affinity peptidomimetics against α4β1 integrin for in vivo tumor imaging , 2006 .

[35]  Araz Jakalian,et al.  Fast, efficient generation of high‐quality atomic charges. AM1‐BCC model: I. Method , 2000 .

[36]  R J Leatherbarrow,et al.  Selection of chymotrypsin inhibitors from a conformationally-constrained combinatorial peptide library. , 1996, Journal of molecular biology.

[37]  S. Devaraj,et al.  Effect of C-reactive protein on chemokine expression in human aortic endothelial cells. , 2004, Journal of molecular and cellular cardiology.

[38]  P. Libby,et al.  Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. , 2004, The American journal of medicine.

[39]  T. D. Du Clos,et al.  The biological effects of CRP are not attributable to endotoxin contamination: evidence from TLR4 knockdown human aortic endothelial cells Published, JLR Papers in Press, December 11, 2006. , 2007, Journal of Lipid Research.

[40]  K. Lam,et al.  Development of inhibitors for protein tyrosine kinases , 2000, Oncogene.

[41]  K. Lam,et al.  Synthesis and screening of "one-bead one-compound" combinatorial peptide libraries. , 2005, Methods in enzymology.

[42]  David S. Goodsell,et al.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..

[43]  Paul A. Bartlett,et al.  Screening Chemical Microarrays: Methods and Applications , 2006 .

[44]  Sridevi Devaraj,et al.  The evolving role of C-reactive protein in atherothrombosis. , 2009, Clinical chemistry.